ARCHIVES

NCI advisors approved in concept the Institute’s plan to spend $24 million over five years for research on “patient navigator” programs.

This article is from The Cancer Letter archive.

Vol. 30 No. 13 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

NCI To Broaden Support, Especially For Staff, Through Core Grants to Comprehensive Centers

November 21, 1975

In Congress: Senate, House Reports List Priorities For NCI

August 8, 1997

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

Center Program Move Definite; DCBD to Be Renamed

September 22, 1989

In Brief: Kennedy To Hold Hearing on Mammography Reimbursement, Waxman On Reauthrization

January 15, 1988